Các bài viết có thể truy cập công khai - Martin HojgaardTìm hiểu thêm
Có tại một số nơi: 6
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
F Doz, CM Van Tilburg, B Geoerger, M Højgaard, I Øra, V Boni, M Capra, ...
Neuro-oncology 24 (6), 997-1007, 2022
Các cơ quan ủy nhiệm: US National Institutes of Health, National Institute for Health Research, UK
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results
TA Yap, E Fontana, EK Lee, DR Spigel, M Højgaard, S Lheureux, ...
Nature medicine 29 (6), 1400-1411, 2023
Các cơ quan ủy nhiệm: US National Institutes of Health, Cancer Research UK
Modeling metastatic colonization in a decellularized organ scaffold‐based perfusion bioreactor
M Rafaeva, ER Horton, ARD Jensen, CD Madsen, R Reuten, O Willacy, ...
Advanced healthcare materials 11 (1), 2100684, 2022
Các cơ quan ủy nhiệm: Swedish Research Council, European Commission, Innovation Fund Denmark
Development of a practical nomogram for personalized anemia management in patients treated with ataxia telangiectasia and rad3-related inhibitor camonsertib
E Rosen, TA Yap, EK Lee, M Højgaard, NB Mettu, S Lheureux, ...
Clinical Cancer Research 30 (4), 687-694, 2024
Các cơ quan ủy nhiệm: US National Institutes of Health
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)
E Fontana, E Rosen, EK Lee, M Højgaard, NB Mettu, S Lheureux, ...
JNCI: Journal of the National Cancer Institute 116 (9), 1439-1449, 2024
Các cơ quan ủy nhiệm: Cancer Research UK
8P Pharmacokinetic (PK) profile and food effect of RP-3500, a highly potent and specific inhibitor of ataxia telangiectasia and Rad3-related (ATR) protein kinase in patients …
S Lheureux, E Rosen, E Lee, D Spigel, M Højgaard, E Fontana, NB Mettu, ...
Annals of Oncology 33, S4-S5, 2022
Các cơ quan ủy nhiệm: US National Institutes of Health
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ